CME Group Inc. today announced it priced an underwritten public offering of $750 million aggregate principal amount of 5.75% notes due 2014. The offering is being made under CME Group's existing shelf registration statement and is expected to close on February 9, 2009, subject to customary closing conditions.
CME Group intends to use the net proceeds from the offering to repay any outstanding commercial paper borrowings that are backstopped by the company's 364-day revolving bridge facility. The company will use the remaining net proceeds from the offering for general corporate purposes. The company expects to terminate the bridge facility following the offering.
This announcement is neither an offer to sell nor a solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offers of the notes will be made exclusively by means of a prospectus and prospectus supplement.
Banc of America Securities LLC, UBS Securities LLC, Barclays Capital Inc. and Lloyds TSB Bank plc are acting as representatives of the underwriters. Copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained by contacting Banc of America Securities LLC, Prospectus Department, 100 West 33rd Street, 3rd Floor, New York, New York 10001, 800-294-1322; UBS Securities LLC, 299 Park Avenue, New York, NY 10171, Prospectus Specialist, Attn: Clint Lauriston, toll free 877-827-6444 ext 561 3884; Barclays Capital Inc., 200 Park Avenue, New York, NY 10166, Attention: Investment Grade Syndicate, toll free 1-888-227-2275 (ext. 2663); or Lloyds TSB Corporate Markets, Debt Capital Markets, 10 Gresham Street, London, EC2V 7AE at + 44 207 158 2016.